ProCE Banner Series

A New Era of Early-Stage Cancer Care: Clinical Impact of Pathologic Response to Immunotherapy

To Register: Please click the green “Learn More” button below. On the next page, select either “Register Now - In-Person” or “Register Now - Virtual”. Once registered, you will receive a confirmation email. Follow-up emails with event details will be sent as the event nears.

Clinical Care Options, LLC. is committed to providing a safe and healthy environment for all our learners. Our decisions and preventive measures are guided by the requirements and recommendations of the CDC alongside federal, state, and local health authorities. We work with each program venue to implement preventive measures to reduce the potential spread of COVID-19.

For more information on AACR’s vaccination and mask requirements, please visit: AACR’s website

This symposium is sponsored by Clinical Care Options, LLC. and supported by a grant from Bristol Myers Squibb. This is not an official program of the American Association for Cancer Research Annual Meeting.

  AMA
Who Should Attend

This program is intended for pathologists, oncologists, pulmonologists, surgeons, clinical investigators, and other healthcare professionals involved in the treatment of patients with solid tumors.

All Events

A New Era of Early-Stage Cancer Care: Clinical Impact of Pathologic Response to Immunotherapy

Past Events

April

15

2023

6:30 PM - 9:00 PM Eastern Time (ET)

In-personVirtual

Rosen Centre Hotel, 9840 International Dr, Orlando, Florida 32819

Faculty

ProCE Banner Faculty
Patrick Forde, MBBCh

Director, Thoracic Oncology Research Program
Oncology Department
Johns Hopkins University
Baltimore, Maryland

ProCE Banner Faculty
Michael T. Tetzlaff, MD, PhD

Professor of Pathology
Division of Dermatopathology
University of California at San Francisco
San Francisco, California

Additional Info

There are no fees required to participate in this activity.

Americans With Disabilities Act 
Event staff will be glad to assist you with any special needs (eg, physical, dietary). Please contact meetings@clinicaloptions.com prior to the live event.

CME/CE Info

Program Overview
Join us either in person at the 2023 AACR annual meeting or virtually for this 2-hour live, CME-certified satellite symposium. This interactive event features expert perspectives on the evolving role of pathological response assessment in the neoadjuvant setting to guide clinical research, therapeutic decisions, and patient management. Bring your questions for the question-and-answer session with the expert faculty.

Goal Statement
The goal of this program is to improve the knowledge, competence, and performance of learners in the optimal application of pathologic response as a marker to guide therapy and assess clinical trial data with the use of immunotherapy in the neoadjuvant setting.

Target Audience
This program is intended for pathologists, oncologists, pulmonologists, surgeons, clinical investigators, and other healthcare professionals involved in the treatment of patients with solid tumors.

Learning Objectives
Upon completion of this activity, participants should be able to:

    • Discuss with colleagues the differences between pathologic response scoring systems for neoadjuvant chemotherapy vs immunotherapy and their use as a surrogate endpoint for survival when designing or interpreting clinical trials
    • Utilize immune-related pathologic response scoring systems to assess pathologic response in patients undergoing neoadjuvant immunotherapy, considering the differences between response to chemotherapy vs immune checkpoint inhibitor-based therapy
    • Plan neoadjuvant therapeutic strategies using immunotherapies for appropriate patients with early-stage cancer
    • Develop therapeutic strategies for patients that do not achieve a pathologic complete response to neoadjuvant immunotherapy using available clinical evidence and expert guidance

Accreditation

Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Physician Continuing Medical Education

Designation of Credit

CCO designates this live activity for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure of Conflicts of Interest 
Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

Acknowledgement

Provided by Clinical Care Options, LLC.

Supported by an educational grant from Bristol Myers Squibb.